Global Biosimilar Market Growth 2020-2025
According to this study, over the next five years the Biosimilar market will register a 25.9%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Biosimilar business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Biosimilar market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Biosimilar, covering the supply chain analysis, impact assessment to the Biosimilar market size growth rate in several scenarios, and the measures to be undertaken by Biosimilar companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Human Growth Hormones
Monoclonal Antibodies
Insulin
Peptides
Erythropoietin
Others
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Oncology
Chronic and Autoimmune Diseases
Growth Hormone Deficiency
Infectious Diseases
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Allergan plc
Intas Pharmaceuticals Limited
BIOCAD
BioXpress Therapeutics
Boehringer Ingelheim
Biocon
Dr. Reddy's Laboratories
Celltrion
Genor BioPharma
Coherus BioSciences
Novartis
Pfizer
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Biosimilar consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Biosimilar market by identifying its various subsegments.
Focuses on the key global Biosimilar manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Biosimilar with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Biosimilar submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Biosimilar Consumption 2015-2025
2.1.2 Biosimilar Consumption CAGR by Region
2.2 Biosimilar Segment by Type
2.2.1 Human Growth Hormones
2.2.2 Monoclonal Antibodies
2.2.3 Insulin
2.2.4 Peptides
2.2.5 Erythropoietin
2.2.6 Others
2.3 Biosimilar Consumption by Type
2.3.1 Global Biosimilar Consumption Market Share by Type (2015-2020)
2.3.2 Global Biosimilar Revenue and Market Share by Type (2015-2020)
2.3.3 Global Biosimilar Sale Price by Type (2015-2020)
2.4 Biosimilar Segment by Application
2.4.1 Oncology
2.4.2 Chronic and Autoimmune Diseases
2.4.3 Growth Hormone Deficiency
2.4.4 Infectious Diseases
2.4.5 Others
2.5 Biosimilar Consumption by Application
2.5.1 Global Biosimilar Consumption Market Share by Type (2015-2020)
2.5.2 Global Biosimilar Value and Market Share by Type (2015-2020)
2.5.3 Global Biosimilar Sale Price by Type (2015-2020)
3 Global Biosimilar by Company
3.1 Global Biosimilar Sales Market Share by Company
3.1.1 Global Biosimilar Sales by Company (2018-2020)
3.1.2 Global Biosimilar Sales Market Share by Company (2018-2020)
3.2 Global Biosimilar Revenue Market Share by Company
3.2.1 Global Biosimilar Revenue by Company (2018-2020)
3.2.2 Global Biosimilar Revenue Market Share by Company (2018-2020)
3.3 Global Biosimilar Sale Price by Company
3.4 Global Biosimilar Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Biosimilar Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Biosimilar Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Biosimilar by Regions
4.1 Biosimilar by Regions
4.2 Americas Biosimilar Consumption Growth
4.3 APAC Biosimilar Consumption Growth
4.4 Europe Biosimilar Consumption Growth
4.5 Middle East & Africa Biosimilar Consumption Growth
5 Americas
5.1 Americas Biosimilar Consumption by Countries
5.1.1 Americas Biosimilar Consumption by Countries (2015-2020)
5.1.2 Americas Biosimilar Value by Countries (2015-2020)
5.2 Americas Biosimilar Consumption by Type
5.3 Americas Biosimilar Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Biosimilar Consumption by Regions
6.1.1 APAC Biosimilar Consumption by Regions (2015-2020)
6.1.2 APAC Biosimilar Value by Regions (2015-2020)
6.2 APAC Biosimilar Consumption by Type
6.3 APAC Biosimilar Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Biosimilar by Countries
7.1.1 Europe Biosimilar Consumption by Countries (2015-2020)
7.1.2 Europe Biosimilar Value by Countries (2015-2020)
7.2 Europe Biosimilar Consumption by Type
7.3 Europe Biosimilar Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Biosimilar by Countries
8.1.1 Middle East & Africa Biosimilar Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Biosimilar Value by Countries (2015-2020)
8.2 Middle East & Africa Biosimilar Consumption by Type
8.3 Middle East & Africa Biosimilar Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Biosimilar Distributors
10.3 Biosimilar Customer
11 Global Biosimilar Market Forecast
11.1 Global Biosimilar Consumption Forecast (2021-2025)
11.2 Global Biosimilar Forecast by Regions
11.2.1 Global Biosimilar Forecast by Regions (2021-2025)
11.2.2 Global Biosimilar Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast byRegions
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Biosimilar Forecast by Type
11.8 Global Biosimilar Forecast by Application
12 Key Players Analysis
12.1 Allergan plc
12.1.1 Company Information
12.1.2 Biosimilar Product Offered
12.1.3 Allergan plc Biosimilar Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Allergan plc Latest Developments
12.2 Intas Pharmaceuticals Limited
12.2.1 Company Information
12.2.2 Biosimilar Product Offered
12.2.3 Intas Pharmaceuticals Limited Biosimilar Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Intas Pharmaceuticals Limited Latest Developments
12.3 BIOCAD
12.3.1 Company Information
12.3.2 Biosimilar Product Offered
12.3.3 BIOCAD Biosimilar Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 BIOCAD Latest Developments
12.4 BioXpress Therapeutics
12.4.1 Company Information
12.4.2 Biosimilar Product Offered
12.4.3 BioXpress Therapeutics Biosimilar Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 BioXpress Therapeutics Latest Developments
12.5 Boehringer Ingelheim
12.5.1 Company Information
12.5.2 Biosimilar Product Offered
12.5.3 Boehringer Ingelheim Biosimilar Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Boehringer Ingelheim Latest Developments
12.6 Biocon
12.6.1 Company Information
12.6.2 Biosimilar Product Offered
12.6.3 Biocon Biosimilar Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Biocon Latest Developments
12.7 Dr. Reddy's Laboratories
12.7.1 Company Information
12.7.2 Biosimilar Product Offered
12.7.3 Dr. Reddy's Laboratories Biosimilar Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Dr. Reddy's Laboratories Latest Developments
12.8 Celltrion
12.8.1 Company Information
12.8.2 Biosimilar Product Offered
12.8.3 Celltrion Biosimilar Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Celltrion Latest Developments
12.9 Genor BioPharma
12.9.1 Company Information
12.9.2 Biosimilar Product Offered
12.9.3 Genor BioPharma Biosimilar Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Genor BioPharma Latest Developments
12.10 Coherus BioSciences
12.10.1 Company Information
12.10.2 Biosimilar Product Offered
12.10.3 Coherus BioSciences Biosimilar Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Coherus BioSciences Latest Developments
12.11 Novartis
12.11.1 Company Information
12.11.2 Biosimilar Product Offered
12.11.3 Novartis Biosimilar Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Novartis Latest Developments
12.12 Pfizer
12.12.1 Company Information
12.12.2 Biosimilar Product Offered
12.12.3 Pfizer Biosimilar Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 Pfizer Latest Developments
13 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Biosimilar Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Human Growth Hormones
Table 5. Major Players of Monoclonal Antibodies
Table 6. Major Players of Insulin
Table 7. Major Players of Peptides
Table 8. Major Players of Erythropoietin
Table 9. Major Players of Others
Table 10. Global Consumption Sales by Type (2015-2020)
Table 11. Global Biosimilar Consumption Market Share by Type (2015-2020)
Table 12. Global Biosimilar Revenue by Type (2015-2020) ($ million)
Table 13. Global Biosimilar Value Market Share by Type (2015-2020) ($ Millions)
Table 14. Global Biosimilar Sale Price by Type (2015-2020)
Table 15. Global Consumption Sales by Application (2015-2020)
Table 16. Global Biosimilar Consumption Market Share by Application (2015-2020)
Table 17. Global Biosimilar Value by Application (2015-2020)
Table 18. Global Biosimilar Value Market Share by Application (2015-2020)
Table 19. Global Biosimilar Sale Price by Application (2015-2020)
Table 20. Global Biosimilar Sales by Company (2017-2019) (K Units)
Table 21. Global Biosimilar Sales Market Share by Company (2017-2019)
Table 22. Global Biosimilar Revenue by Company (2017-2019) ($ Millions)
Table 23. Global Biosimilar Revenue Market Share by Company (2017-2019)
Table 24. Global Biosimilar Sale Price by Company (2017-2019)
Table 25. Global Biosimilar Manufacturing Base Distribution and Sales Area by Manufacturers
Table 26. Players Biosimilar Products Offered
Table 27. Biosimilar Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 28. Global Biosimilar Consumption by Regions 2015-2020 (K Units)
Table 29. Global Biosimilar Consumption Market Share by Regions 2015-2020
Table 30. Global Biosimilar Value by Regions 2015-2020 ($ Millions)
Table 31. Global Biosimilar Value Market Share by Regions 2015-2020
Table 32. Americas Biosimilar Consumption by Countries (2015-2020) (K Units)
Table 33. Americas Biosimilar Consumption Market Share by Countries (2015-2020)
Table 34. Americas Biosimilar Value by Countries (2015-2020) ($ Millions)
Table 35. Americas Biosimilar Value Market Share by Countries (2015-2020)
Table 36. Americas Biosimilar Consumption by Type (2015-2020) (K Units)
Table 37. Americas Biosimilar Consumption Market Share by Type (2015-2020)
Table 38. Americas Biosimilar Consumption by Application (2015-2020) (K Units)
Table 39. Americas Biosimilar Consumption Market Share by Application (2015-2020)
Table 40. APAC Biosimilar Consumption by Regions (2015-2020) (K Units)
Table 41. APAC Biosimilar Consumption Market Share by Regions (2015-2020)
Table 42. APAC Biosimilar Value by Regions (2015-2020) ($ Millions)
Table 43. APAC Biosimilar Value Market Share by Regions (2015-2020)
Table 44. APAC Biosimilar Consumption by Type (2015-2020) (K Units)
Table 45. APAC Biosimilar Consumption Market Share by Type (2015-2020)
Table 46. APAC Biosimilar Consumption by Application (2015-2020) (K Units)
Table 47. APAC Biosimilar Consumption Market Share by Application (2015-2020)
Table 48. Europe Biosimilar Consumption by Countries (2015-2020) (K Units)
Table 49. Europe Biosimilar Consumption Market Share by Countries (2015-2020)
Table 50. Europe Biosimilar Value by Countries (2015-2020) ($ Millions)
Table 51. Europe Biosimilar Value Market Share by Countries (2015-2020)
Table 52. Europe Biosimilar Consumption by Type (2015-2020) (K Units)
Table 53. Europe Biosimilar Consumption Market Share by Type (2015-2020)
Table 54. Europe Biosimilar Consumption by Application (2015-2020) (K Units)
Table 55. Europe Biosimilar Consumption Market Share by Application (2015-2020)
Table 56. Middle East & Africa Biosimilar Consumption by Countries (2015-2020) (K Units)
Table 57. Middle East & Africa Biosimilar Consumption Market Share by Countries (2015-2020)
Table 58. Middle East & Africa Biosimilar Value by Countries (2015-2020) ($ Millions)
Table 59. Middle East & Africa Biosimilar Value Market Share by Countries (2015-2020)
Table 60. Middle East & Africa Biosimilar Consumption by Type (2015-2020) (K Units)
Table 61. Middle East & Africa Biosimilar Consumption Market Share by Type (2015-2020)
Table 62. Middle East & Africa Biosimilar Consumption by Application (2015-2020) (K Units)
Table 63. Middle East & Africa Biosimilar Consumption Market Share by Application (2015-2020)
Table 64. Biosimilar Distributors List
Table 65. Biosimilar Customer List
Table 66. Global Biosimilar Consumption Forecast by Countries (2021-2025) (K Units)
Table 67. Global Biosimilar Consumption Market Forecast by Regions
Table 68. Global Biosimilar Value Forecast by Countries (2021-2025) ($ Millions)
Table 69. Global Biosimilar Value Market Share Forecast by Regions
Table 70. Global Biosimilar Consumption Forecast by Type (2021-2025) (K Units)
Table 71. Global Biosimilar Consumption Market Share Forecast by Type (2021-2025)
Table 72. Global Biosimilar Value Forecast by Type (2021-2025) ($ Millions)
Table 73. Global Biosimilar Value Market Share Forecast by Type (2021-2025)
Table 74. Global Biosimilar Consumption Forecast by Application (2021-2025) (K Units)
Table 75. Global Biosimilar Consumption Market Share Forecast by Application (2021-2025)
Table 76. Global Biosimilar Value Forecast by Application (2021-2025) ($ Millions)
Table 77. Global Biosimilar Value Market Share Forecast by Application (2021-2025)
Table 78. Allergan plc Product Offered
Table 79. Allergan plc Biosimilar Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 80. Allergan plc Main Business
Table 81. Allergan plc Latest Developments
Table 82. Allergan plc Basic Information, Company Total Revenue (in $ million), Biosimilar Manufacturing Base, Sales Area and Its Competitors
Table 83. Intas Pharmaceuticals Limited Product Offered
Table 84. Intas Pharmaceuticals Limited Biosimilar Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 85. Intas Pharmaceuticals Limited Main Business
Table 86. Intas Pharmaceuticals Limited Latest Developments
Table 87. Intas Pharmaceuticals Limited Basic Information, Company Total Revenue (in $ million), Biosimilar Manufacturing Base, Sales Area and Its Competitors
Table 88. BIOCAD Product Offered
Table 89. BIOCAD Biosimilar Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 90. BIOCAD Main Business
Table 91. BIOCAD Latest Developments
Table 92. BIOCAD Basic Information, Company Total Revenue (in $ million), Biosimilar Manufacturing Base, Sales Area and Its Competitors
Table 93. BioXpress Therapeutics Product Offered
Table 94. BioXpress Therapeutics Biosimilar Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 95. BioXpress Therapeutics Main Business
Table 96. BioXpress Therapeutics Latest Developments
Table 97. BioXpress Therapeutics Basic Information, Company Total Revenue (in $ million), Biosimilar Manufacturing Base, Sales Area and Its Competitors
Table 98. Boehringer Ingelheim Product Offered
Table 99. Boehringer Ingelheim Biosimilar Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 100. Boehringer Ingelheim Main Business
Table 101. Boehringer Ingelheim Latest Developments
Table 102. Boehringer Ingelheim Basic Information, Company Total Revenue (in $ million), Biosimilar Manufacturing Base, Sales Area and Its Competitors
Table 103. Biocon Product Offered
Table 104. Biocon Biosimilar Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 105. Biocon Main Business
Table 106. Biocon Latest Developments
Table 107. Biocon Basic Information, Company Total Revenue (in $ million), Biosimilar Manufacturing Base, Sales Area and Its Competitors
Table 108. Dr. Reddy's Laboratories Product Offered
Table 109. Dr. Reddy's Laboratories Basic Information, Company Total Revenue (in $ million), Biosimilar Manufacturing Base, Sales Area and Its Competitors
Table 110. Dr. Reddy's Laboratories Main Business
Table 111. Dr. Reddy's Laboratories Latest Developments
Table 112. Dr. Reddy's Laboratories Biosimilar Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 113. Celltrion Product Offered
Table 114. Celltrion Biosimilar Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 115. Celltrion Main Business
Table 116. Celltrion Latest Developments
Table 117. Celltrion Basic Information, Company Total Revenue (in $ million), Biosimilar Manufacturing Base, Sales Area and Its Competitors
Table 118. Genor BioPharma Product Offered
Table 119. Genor BioPharma Biosimilar Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 120. Genor BioPharma Main Business
Table 121. Genor BioPharma Latest Developments
Table 122. Genor BioPharma Basic Information, Company Total Revenue (in $ million), Biosimilar Manufacturing Base, Sales Area and Its Competitors
Table 123. Coherus BioSciences Product Offered
Table 124. Coherus BioSciences Biosimilar Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 125. Coherus BioSciences Main Business
Table 126. Coherus BioSciences Latest Developments
Table 127. Coherus BioSciences Basic Information, Company Total Revenue (in $ million), Biosimilar Manufacturing Base, Sales Area and Its Competitors
Table 128. Novartis Product Offered
Table 129. Novartis Biosimilar Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 130. Novartis Main Business
Table 131. Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 132. Novartis Latest Developments
Table 133. Pfizer Product Offered
Table 134. Pfizer Biosimilar Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 135. Pfizer Main Business
Table 136. Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 137. Pfizer Latest Developments
List of Figures
Figure 1. Picture of Biosimilar
Figure 2. Biosimilar Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Biosimilar Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global Biosimilar Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Human Growth Hormones
Figure 7. Product Picture of Monoclonal Antibodies
Figure 8. Product Picture of Insulin
Figure 9. Product Picture of Peptides
Figure 10. Product Picture of Erythropoietin
Figure 11. Product Picture of Others
Figure 12. Global Biosimilar Consumption Market Share by Type (2015-2020)
Figure 13. Global Biosimilar Value Market Share by Type (2015-2020)
Figure 14. Biosimilar Consumed in Oncology
Figure 15. Global Biosimilar Market: Oncology (2015-2020) (K Units)
Figure 16. Global Biosimilar Market: Oncology (2015-2020) ($ Millions)
Figure 17. Biosimilar Consumed in Chronic and Autoimmune Diseases
Figure 18. Global Biosimilar Market: Chronic and Autoimmune Diseases (2015-2020) (K Units)
Figure 19. Global Biosimilar Market: Chronic and Autoimmune Diseases (2015-2020) ($ Millions)
Figure 20. Biosimilar Consumed in Growth Hormone Deficiency
Figure 21. Global Biosimilar Market: Growth Hormone Deficiency (2015-2020) (K Units)
Figure 22. Global Biosimilar Market: Growth Hormone Deficiency (2015-2020) ($ Millions)
Figure 23. Biosimilar Consumed in Infectious Diseases
Figure 24. Global Biosimilar Market: Infectious Diseases (2015-2020) (K Units)
Figure 25. Global Biosimilar Market: Infectious Diseases (2015-2020) ($ Millions)
Figure 26. Biosimilar Consumed in Others
Figure 27. Global Biosimilar Market: Others (2015-2020) (K Units)
Figure 28. Global Biosimilar Market: Others (2015-2020) ($ Millions)
Figure 29. Global Biosimilar Consumption Market Share by Application (2015-2020)
Figure 30. Global Biosimilar Value Market Share by Application (2015-2020)
Figure 31. Global Biosimilar Sales Market Share by Company in 2017
Figure 32. Global Biosimilar Sales Market Share by Company in 2019
Figure 33. Global Biosimilar Revenue Market Share by Company in 2017
Figure 34. Global Biosimilar Revenue Market Share by Company in 2019
Figure 35. Global Biosimilar Sale Price by Company in 2019
Figure 36. Global Biosimilar Consumption Market Share by Regions 2015-2020
Figure 37. Global Biosimilar Value Market Share by Regions 2015-2020
Figure 38. Americas Biosimilar Consumption 2015-2020 (K Units)
Figure 39. Americas Biosimilar Value 2015-2020 ($ Millions)
Figure 40. APAC Biosimilar Consumption 2015-2020 (K Units)
Figure 41. APAC Biosimilar Value 2015-2020 ($ Millions)
Figure 42. Europe Biosimilar Consumption 2015-2020 (K Units)
Figure 43. Europe Biosimilar Value 2015-2020 ($ Millions)
Figure 44. Middle East & Africa Biosimilar Consumption 2015-2020 (K Units)
Figure 45. Middle East & Africa Biosimilar Value 2015-2020 ($ Millions)
Figure 46. Americas Biosimilar Consumption Market Share by Countries in 2019
Figure 47. Americas Biosimilar Value Market Share by Countries in 2019
Figure 48. Americas Biosimilar Consumption Market Share by Type in 2019
Figure 49. Americas Biosimilar Consumption Market Share by Application in 2019
Figure 50. United States Biosimilar Consumption Growth 2015-2020 (K Units)
Figure 51. United States Biosimilar Value Growth 2015-2020 ($ Millions)
Figure 52. Canada Biosimilar Consumption Growth 2015-2020 (K Units)
Figure 53. Canada Biosimilar Value Growth 2015-2020 ($ Millions)
Figure 54. Mexico Biosimilar Consumption Growth 2015-2020 (K Units)
Figure 55. Mexico Biosimilar Value Growth 2015-2020 ($ Millions)
Figure 56. APAC Biosimilar Consumption Market Share by Countries in 2019
Figure 57. APAC Biosimilar Value Market Share by Regions in 2019
Figure 58. APAC Biosimilar Consumption Market Share by Type in 2019
Figure 59. APAC Biosimilar Consumption Market Share by Application in 2019
Figure 60. China Biosimilar Consumption Growth 2015-2020 (K Units)
Figure 61. China Biosimilar Value Growth 2015-2020 ($ Millions)
Figure 62. Japan Biosimilar Consumption Growth 2015-2020 (K Units)
Figure 63. Japan Biosimilar Value Growth 2015-2020 ($ Millions)
Figure 64. Korea Biosimilar Consumption Growth 2015-2020 (K Units)
Figure 65. Korea Biosimilar Value Growth 2015-2020 ($ Millions)
Figure 66. Southeast Asia Biosimilar Consumption Growth 2015-2020 (K Units)
Figure 67. Southeast Asia Biosimilar Value Growth 2015-2020 ($ Millions)
Figure 68. India Biosimilar Consumption Growth 2015-2020 (K Units)
Figure 69. India Biosimilar Value Growth 2015-2020 ($ Millions)
Figure 70. Australia Biosimilar Consumption Growth 2015-2020 (K Units)
Figure 71. Australia Biosimilar Value Growth 2015-2020 ($ Millions)
Figure 72. Europe Biosimilar Consumption Market Share by Countries in 2019
Figure 73. Europe Biosimilar Value Market Share by Countries in 2019
Figure 74. Europe Biosimilar Consumption Market Share by Type in 2019
Figure 75. Europe Biosimilar Consumption Market Share by Application in 2019
Figure 76. Germany Biosimilar Consumption Growth 2015-2020 (K Units)
Figure 77. Germany Biosimilar Value Growth 2015-2020 ($ Millions)
Figure 78. France Biosimilar Consumption Growth 2015-2020 (K Units)
Figure 79. France Biosimilar Value Growth 2015-2020 ($ Millions)
Figure 80. UK Biosimilar Consumption Growth 2015-2020 (K Units)
Figure 81. UK Biosimilar Value Growth 2015-2020 ($ Millions)
Figure 82. Italy Biosimilar Consumption Growth 2015-2020 (K Units)
Figure 83. Italy Biosimilar Value Growth 2015-2020 ($ Millions)
Figure 84. Russia Biosimilar Consumption Growth 2015-2020 (K Units)
Figure 85. Russia Biosimilar Value Growth 2015-2020 ($ Millions)
Figure 86. Middle East & Africa Biosimilar Consumption Market Share by Countries in 2019
Figure 87. Middle East & Africa Biosimilar Value Market Share by Countries in 2019
Figure 88. Middle East & Africa Biosimilar Consumption Market Share by Type in 2019
Figure 89. Middle East & Africa Biosimilar Consumption Market Share by Application in 2019
Figure 90. Egypt Biosimilar Consumption Growth 2015-2020 (K Units)
Figure 91. Egypt Biosimilar Value Growth 2015-2020 ($ Millions)
Figure 92. South Africa Biosimilar Consumption Growth 2015-2020 (K Units)
Figure 93. South Africa Biosimilar Value Growth 2015-2020 ($ Millions)
Figure 94. Israel Biosimilar Consumption Growth 2015-2020 (K Units)
Figure 95. Israel Biosimilar Value Growth 2015-2020 ($ Millions)
Figure 96. Turkey Biosimilar Consumption Growth 2015-2020 (K Units)
Figure 97. Turkey Biosimilar Value Growth 2015-2020 ($ Millions)
Figure 98. GCC Countries Biosimilar Consumption Growth 2015-2020 (K Units)
Figure 99. GCC Countries Biosimilar Value Growth 2015-2020 ($ Millions)
Figure 100. Global Biosimilar Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 101. Global Biosimilar Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 102. Americas Biosimilar Consumption 2021-2025 (K Units)
Figure 103. Americas Biosimilar Value 2021-2025 ($ Millions)
Figure 104. APAC Biosimilar Consumption 2021-2025 (K Units)
Figure 105. APAC Biosimilar Value 2021-2025 ($ Millions)
Figure 106. Europe Biosimilar Consumption 2021-2025 (K Units)
Figure 107. Europe Biosimilar Value 2021-2025 ($ Millions)
Figure 108. Middle East & Africa Biosimilar Consumption 2021-2025 (K Units)
Figure 109. Middle East & Africa Biosimilar Value 2021-2025 ($ Millions)
Figure 110. United States Biosimilar Consumption 2021-2025 (K Units)
Figure 111. United States Biosimilar Value 2021-2025 ($ Millions)
Figure 112. Canada Biosimilar Consumption 2021-2025 (K Units)
Figure 113. Canada Biosimilar Value 2021-2025 ($ Millions)
Figure 114. Mexico Biosimilar Consumption 2021-2025 (K Units)
Figure 115. Mexico Biosimilar Value 2021-2025 ($ Millions)
Figure 116. Brazil Biosimilar Consumption 2021-2025 (K Units)
Figure 117. Brazil Biosimilar Value 2021-2025 ($ Millions)
Figure 118. China Biosimilar Consumption 2021-2025 (K Units)
Figure 119. China Biosimilar Value 2021-2025 ($ Millions)
Figure 120. Japan Biosimilar Consumption 2021-2025 (K Units)
Figure 121. Japan Biosimilar Value 2021-2025 ($ Millions)
Figure 122. Korea Biosimilar Consumption 2021-2025 (K Units)
Figure 123. Korea Biosimilar Value 2021-2025 ($ Millions)
Figure 124. Southeast Asia Biosimilar Consumption 2021-2025 (K Units)
Figure 125. Southeast Asia Biosimilar Value 2021-2025 ($ Millions)
Figure 126. India Biosimilar Consumption 2021-2025 (K Units)
Figure 127. India Biosimilar Value 2021-2025 ($ Millions)
Figure 128. Australia Biosimilar Consumption 2021-2025 (K Units)
Figure 129. Australia Biosimilar Value 2021-2025 ($ Millions)
Figure 130. Germany Biosimilar Consumption 2021-2025 (K Units)
Figure 131. Germany Biosimilar Value 2021-2025 ($ Millions)
Figure 132. France Biosimilar Consumption 2021-2025 (K Units)
Figure 133. France Biosimilar Value 2021-2025 ($ Millions)
Figure 134. UK Biosimilar Consumption 2021-2025 (K Units)
Figure 135. UK Biosimilar Value 2021-2025 ($ Millions)
Figure 136. Italy Biosimilar Consumption 2021-2025 (K Units)
Figure 137. Italy Biosimilar Value 2021-2025 ($ Millions)
Figure 138. Russia Biosimilar Consumption 2021-2025 (K Units)
Figure 139. Russia Biosimilar Value 2021-2025 ($ Millions)
Figure 140. Spain Biosimilar Consumption 2021-2025 (K Units)
Figure 141. Spain Biosimilar Value 2021-2025 ($ Millions)
Figure 142. Egypt Biosimilar Consumption 2021-2025 (K Units)
Figure 143. Egypt Biosimilar Value 2021-2025 ($ Millions)
Figure 144. South Africa Biosimilar Consumption 2021-2025 (K Units)
Figure 145. South Africa Biosimilar Value 2021-2025 ($ Millions)
Figure 146. Israel Biosimilar Consumption 2021-2025 (K Units)
Figure 147. Israel Biosimilar Value 2021-2025 ($ Millions)
Figure 148. Turkey Biosimilar Consumption 2021-2025 (K Units)
Figure 149. Turkey Biosimilar Value 2021-2025 ($ Millions)
Figure 150. GCC Countries Biosimilar Consumption 2021-2025 (K Units)
Figure 151. GCC Countries Biosimilar Value 2021-2025 ($ Millions)
Figure 152. Allergan plc Biosimilar Market Share (2018-2020)
Figure 153. Intas Pharmaceuticals Limited Biosimilar Market Share (2018-2020)
Figure 154. BIOCAD Biosimilar Market Share (2018-2020)
Figure 155. BioXpress Therapeutics Biosimilar Market Share (2018-2020)
Figure 156. Boehringer Ingelheim Biosimilar Market Share (2018-2020)
Figure 157. Biocon Biosimilar Market Share (2018-2020)
Figure 158. Dr. Reddy's Laboratories Biosimilar Market Share (2018-2020)
Figure 159. Celltrion Biosimilar Market Share (2018-2020)
Figure 160. Genor BioPharma Biosimilar Market Share (2018-2020)
Figure 161. Coherus BioSciences Biosimilar Market Share (2018-2020)
Figure 162. Novartis Biosimilar Market Share (2018-2020)
Figure 163. Pfizer Biosimilar Market Share (2018-2020)
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets